The production of minitopes (peptides that block IgE but do not trigger an allergic reaction) from modified Jat c 1 IgE-binding peptides, where the strategic glutamic acid residues could be replaced by leucine residues, is a further ASIT possibility. The gene discussed is IGHE; the disease is allergic disease.